Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Vivoryon Therapeutics N.v.

Clinical trials sponsored by Vivoryon Therapeutics N.v., explained in plain language.

New pill aims to slow Alzheimer's decline

Disease control Terminated

This study tested a twice-daily oral medication called varoglutamstat (PQ912) for people with early Alzheimer's disease. The goal was to see if the drug could safely slow the decline in memory and thinking skills. The trial was designed in two parts, starting with about 180 parti…

Phase: PHASE2 • Sponsor: Vivoryon Therapeutics N.V. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC